Cetera Advisor Networks’s Avadel Pharmaceuticals AVDL Stock Holding History

Cetera Advisor Networks’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$368K	Buy	21,811 +9,568	+78%	+$142K	﹤0.01%	2137
2023 Q4	$173K	Buy	12,243 +451	+4%	+$5.3K	﹤0.01%	2571
2023 Q3	$121K	Hold	11,792	–	–	﹤0.01%	2543
2023 Q2	$194K	Sell	11,792 -874	-7%	-$11.4K	﹤0.01%	2360
2023 Q1	$116K	Hold	12,666	–	–	﹤0.01%	2418
2022 Q4	$90.7K	Hold	12,666	–	–	﹤0.01%	2389
2022 Q3	$63K	Hold	12,666	–	–	﹤0.01%	2000
2022 Q2	$31K	Buy	12,666 +696	+6%	+$2.86K	﹤0.01%	2021
2022 Q1	$82K	Hold	11,970	–	–	﹤0.01%	1988
2021 Q4	$97K	Buy	11,970 +1,444	+14%	+$13.2K	﹤0.01%	1961
2021 Q3	$103K	Buy	+10,526	New	+$82.9K	﹤0.01%	1889

Other funds holding AVDL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cetera Advisor Networks's AVDL Position: Q1 2024 in Review

Cetera Advisor Networks increased its Avadel Pharmaceuticals (AVDL) stake by 78% in Q1 2024, buying an estimated $142K and bringing the position to 21,811 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Cetera Advisor Networks first reported a position in AVDL in Q3 2021 and has held it in 11 quarters since. 127 funds tracked by Wall St. Rank hold AVDL as of Q1 2024.

Cetera Advisor Networks held 21,811 shares of Avadel Pharmaceuticals worth $368K as of Q1 2024.
Cetera Advisor Networks bought 9,568 Avadel Pharmaceuticals shares in Q1 2024, an estimated $142K.
Avadel Pharmaceuticals made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2137 holding.
Cetera Advisor Networks first reported a position in Avadel Pharmaceuticals in Q3 2021 and has held it in 11 quarters since.
127 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.